Is Linezolid/Siwo an imported drug?

Linezolid (Linezolid) was developed by Pfizer (Pfizer) and was first launched under the trade name “Zyvox”. It is considered the first representative of the oxazolidinone antibacterial drugs. Its emergence filled the global gap in the treatment of drug-resistant Gram-positive bacteria, so it was initially a typical imported original drug. Linezolid, which was used in the early stage of the Chinese market, also mainly relied on import channels, with "Swo" as the main trade name, and was used to treat serious infections in adults and children, including hospital-acquired pneumonia, community-acquired pneumonia, complex skin and skin structure infections, and vancomycin-resistant enterococcal infections (bacterial infections).

As the patent period gradually expires, some domestic companies have begun to develop and produce generic drugs of linezolid, making the market supply more diversified. According to policy guidance in recent years, linezolid has also been included in the national centralized drug procurement, which has promoted price reduction and improved accessibility. This means that although linezolid was initially a typical imported original drug, there are now both imported versions of Zyvox/Zyvox and domestic generic drugs on the Chinese market. Clinicians can make reasonable choices based on the patient's specific situation and medical insurance coverage.

Whether it is an imported original drug or a domestic generic drug, the active ingredients and main indications of the drug are the same. Overseas clinical studies have fully confirmed its efficacy and safety in treating stubborn infections such as MRSA and VRE. For patients, it is more important to complete the full course of standardized medication under the guidance of a doctor to avoid the risk of drug resistance due to voluntary discontinuation or incorrect use.

Therefore, it can be said that the identity of linezolid has gone through a process from "completely dependent on imports" to "coexistence of domestic production and imports". At present, products represented by Siwo (imported original research) are still in use, while domestic generic drugs play an important complementary role in clinical practice, bringing medication options to more patients.

Reference materials:https://go.drugbank.com/drugs/DB00601